🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsATTAIN-2: orforglipron in T2DM — my results so far Page 3

ATTAIN-2: orforglipron in T2DM — my results so far

roxy_nash Tue, Nov 12, 2024 at 3:57 AM 14 replies 1,740 viewsPage 3 of 3
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Nov 15, 2024 at 11:55 AM#11
Dr.ObesityMed said:
Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent…

That is right for the common case. Whether it is right for the case being asked about depends on a detail that has not been given.

34 7maya_sedona, stefan_berlin, Dr.EM_Chicago and 31 others
Reply Quote Save Share Report
VanRx_Mike
Member
678
2,890
May 2024
Vancouver, CA
Nov 18, 2024 at 4:54 AM#12
BenResearch_OR said:
Orforglipron is a small molecule rather than a peptide, which is the whole point: no SNAC absorption enhancer, no fasting window, no cold chain, and…

Genuinely useful, thank you. I had the facts and not the framework. Sending this to two other people who asked me the same thing last week.

Last edited: Nov 18, 2024 at 7:54 AM
35 8MikeNYC_runner and 32 others
Reply Quote Save Share Report
maya_sedona
Member
289
1,234
Sep 2024
Sedona, AZ
Nov 20, 2024 at 9:52 PM#13
Dr.ObesityMed said:
Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent…

Careful with the causal language. Two things moving together in a period when five things changed is not a mechanism, and stating it as one makes the thread less useful to somebody reading it later.

I would rather be corrected than agreed with, if it comes to it.

Last edited: Nov 21, 2024 at 1:52 AM
36 9BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 33 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
jason_paloalto
Member
212
890
Nov 2024
Palo Alto, CA
Nov 23, 2024 at 2:48 PM#14

The figures, for anyone assembling their own picture. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

Last edited: Nov 23, 2024 at 7:48 PM
37 10andrew_nyc, Dr.EndoEP, GraceAZ_72 and 34 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Nov 26, 2024 at 7:43 AM#15

Moderator note: good thread. Keeping it here rather than moving it, because the question is general enough to be useful.

Last edited: Nov 26, 2024 at 11:43 AM
38 11PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 35 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register